Yaakov Nahmias is the Director of the Alexander Grass Center for Bioengineering at the Hebrew University of Jerusalem, and Founder & Chief Scientific Officer of two biotechnology companies, Future Meat Technologies and Tissue Dynamics. A visionary innovator, his breakthroughs range from the first 3D printing of cells to the first commercial human-on-chip technology. He is the co-founding director of BioDesign-Israel, an
entrepreneurship program that has educated more than 120 fellows and spun off multiple startups, among these Guide-In Medical, CardioVia and
VenoVision. Professor Nahmias’ company, Tissue Dynamics, is developing groundbreaking human-on-a-chip instruments for drug development; and Future Meat Technologies focuses on the cost-effective production of cultured meat. His research team works to develop nanotechnology-based diagnostic devices, innovative medical devices, advanced computational models, and microchip alternatives for animal and human testing.
Prof. Nahmias received his B.S. degree in Chemical Engineering from the Technion-Israel Institute of Technology, and his Ph.D. in Bioengineering from the University of Minnesota. Among his many awards are the National Institute of Health Career Award, European Research Council grants, the Kaye Innovation Award and the Rappaport Prize in Biomedical Research. He is the first scientist outside Britain to win the Rosetrees Trust Prize.